The Eleventh International Cough Symposium

Published: 2020-11-25

Course Director: Professor Kian Fan Chung, Imperial College, London

The Eleventh International Cough Symposium  which was cancelled in June 2020 because of COVID-19 will be held as an interactive virtual event that will take place on 21-22 January 2021. This event will gather clinicians and scientists for a review and discussion of the latest research advances and evolving ideas regarding the cough in clinical disease, pathophysiological mechanisms, and evolving treatments of cough.

It will include state-of–the-art lectures, round-table discussions and poster presentations by an International Faculty. This virtual event will allow for plenty of opportunities for interactions between the faculty and the audience because there will be plenty of time devoted to discussion.

There will be an opportunity for researchers and clinicians to present work in the form of posters that will be discussed in poster discussion sessions.

State-of-the-art lectures

There will be state-of-the-art presentations on the cutting edge of our understanding of cough together with the latest treatment approaches. Sessions will include clinical issues of cough, cough hypersensitivity and sensitisation, and current and future therapeutic approaches.

The John Widdicombe lecture

The John Widdicombe lecture will be delivered by a cough researcher who has made a significant impact in the field of cough.

Poster presentation and Discussion of Abstracts

There will be an opportunity for participants to present their recent work as posters and these will be discussed during the Symposium. Submit a poster.

CPD Credits have been applied for

Learning outcomes

  • Understand the mechanisms underlying cough hypersensitivity syndrome
  • Have a greater knowledge of chronic cough associated with respiratory and non-respiratory disorders
  • Have insight into the current management of patients with chronic cough
  • Have up-to-date information on the most recent advances in antitussive therapies

Target audience
Clinicians in various specialties including internal medicine, respiratory, gastroenterologists, and otorhinolaryngologist, physiotherapists, language and speech therapists, basic scientists and physiologists in sensory neurophysiology, clinical scientists in cough, pain and itch, pharmacologists, and pharmaceutical company scientists.